Everything You Need To Know About Early Stage Parkinson's Disease Clinical Trials
Posted on: 24 May 2022
Share
Parkinson's disease slowly takes everything from its victim while their loved ones watch helplessly. With early-stage Parkinson's disease clinical trials, however, society is finally starting to fight back. Here's what you need to know.
What is early-stage Parkinson's disease?
Early-stage Parkinson's disease (PD) is a neurological disorder that affects the control of movement. The main symptoms are tremors, stiffness, and slowness of movement.
PD usually starts gradually, with mild symptoms that progress over time. In the early stages, PD can be difficult to diagnose because the symptoms may be so mild that they're not noticeable, or they may mimic other conditions.
PD is a progressive disorder, which means the symptoms of Parkinson's disease get worse the longer you have it. While there is no cure for PD, there are some treatments that can bring relief to the symptoms and slow the progression of the disease.
What are clinical trials?
Clinical trials are research studies that test new treatments in people. They are an essential step in the development of new therapies for PD. Trials help us to understand whether a new treatment is safe and effective. They also provide information on side effects and help to determine the best dose of a new drug.
Clinical trials are conducted in phases. Phase I trials test a new drug in a small group of people to assess its safety, side effects, and optimal dose. Phase II trials test the drug in a larger group of people to assess its effectiveness. Phase III trials compare the new drug to the existing standard of care in a large group of people to confirm its effectiveness and safety.
What are early-stage Parkinson's disease clinical trials?
Early-stage Parkinson's disease clinical trials are research studies that test new treatments in people with early-stage PD. These trials help us to understand whether a new treatment is safe and effective in people with PD.
Trials also provide information on side effects and help to determine the best dose of a new drug. Early-stage PD trials are conducted in phases.
What are the benefits and risks of participating in clinical trials?
The benefits of participating in clinical trials include access to new treatments that are not yet available, close monitoring by a medical team, and the opportunity to contribute to medical research. The risks of participating in clinical trials include the possibility of adverse side effects from the new treatment and the time and effort required to participate in the trial.
Before enrolling in a clinical trial, it is important to discuss the risks and benefits with your doctor.
How can I find out about clinical trials for early-stage Parkinson's disease?
The best way to find out about clinical trials for early-stage PD is to speak with your doctor.
What are the costs of early-stage Parkinson's disease clinical trials?
Early-stage Parkinson's disease clinical trials are typically funded by pharmaceutical companies, government agencies, or charitable foundations.
Some clinical trials may require participants to pay for some of the costs of their participation, such as travel expenses. However, many clinical trials will cover all the costs of participation. It is important to discuss the costs of participation with the clinical trial staff before enrolling in a trial.
In conclusion, early-stage Parkinson's disease clinical trials are important research studies that test new treatments in people with early-stage PD. These trials help us to understand whether a new treatment is safe and effective in people with PD and, hopefully, find a cure.
For more information, contact a center like the Institute for Neurodegenerative Disorders.